Suppr超能文献

基于网络药理学的复方苦参注射液抗肿瘤作用的分子生物学机制研究。

Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.

机构信息

Department of Pharmacy, Dongguan People's Hospital, Dongguan, Guangdong, China (mainland).

出版信息

Med Sci Monit. 2020 Jan 1;26:e918520. doi: 10.12659/MSM.918520.

Abstract

BACKGROUND Compound Kushen injection (CKI) is a traditional Chinese medicine preparation for clinical treatment of cancer pain or treatment of various types of solid tumors. The purpose of this study was to identify the main active compounds from CKI and to investigate its anti-cancer mechanisms via drug target biological network pharmacology construction and prediction. MATERIAL AND METHODS Constituents of CKI were retrieved from Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. Disease targets were collected in the Human Gene (Gene Cards) and Human Mendelian Inheritance (OMIM) databases. "Ingredients-protein targets-pathway" networks were constructed using Cytoscape. STRING database platform to construct enrichment of protein-protein interactions (PPI), related diseases and pathways network. Gene Ontology (GO) biological functions and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway of were performed to investigate by using Bioconductor tool for analysis. RESULTS The results indicated that 60 constituents of absorption, distribution, metabolism, and excretion (ADME) filtration resulted in 33 constituents exhibiting significant correlations with anti-cancer and CKI may target 113 proteins, including IL6, EGFR, CASP3, VEGFA, MYC, and ESR1. GO and KEGG enrichment analysis results show that 129 biological processes and 93 signal pathways associated with cancer. It mainly involves cancers such as prostate cancer, bladder cancer, hepatocellular carcinoma, colorectal cancer, breast cancer, etc. Active ingredients might also induce apoptosis in cancer cells via the p53 and PI3K-Akt signaling pathway mechanism. CONCLUSIONS This study was based on pharmacological networks results for the prediction of the multi-constituent, multi-target, and multi-pathway mechanisms of CKI, which might be a promising potential therapeutic and prevention candidate for anti-cancer. However, based on computer data mining and analysis, this study still needs to be further verified by in vivo/in vitro experiments, and the safety of CKI needs to be evaluated.

摘要

背景

复方苦参注射液(CKI)是一种传统的中药制剂,用于临床治疗癌痛或治疗各种实体瘤。本研究旨在通过药物靶点生物网络药理学构建和预测,确定 CKI 的主要活性化合物,并探讨其抗癌机制。

材料和方法

从中药系统药理学(TCMSP)数据库中检索 CKI 的成分。从人类基因(基因卡片)和人类孟德尔遗传(OMIM)数据库中收集疾病靶点。使用 Cytoscape 构建“成分-蛋白靶点-通路”网络。STRING 数据库平台构建富集蛋白-蛋白相互作用(PPI)、相关疾病和通路网络。使用 Bioconductor 工具进行基因本体论(GO)生物功能和京都基因与基因组百科全书(KEGG)通路分析。

结果

结果表明,60 种吸收、分布、代谢和排泄(ADME)过滤成分导致 33 种成分与抗癌有显著相关性,CKI 可能靶向 113 种蛋白质,包括 IL6、EGFR、CASP3、VEGFA、MYC 和 ESR1。GO 和 KEGG 富集分析结果显示,与癌症相关的生物过程有 129 种,信号通路有 93 种。它主要涉及前列腺癌、膀胱癌、肝癌、结直肠癌、乳腺癌等癌症。活性成分也可能通过 p53 和 PI3K-Akt 信号通路机制诱导癌细胞凋亡。

结论

本研究基于药理学网络结果,预测了 CKI 的多成分、多靶点、多途径机制,可能是一种有前途的抗癌治疗和预防候选药物。然而,基于计算机数据挖掘和分析,本研究仍需要进一步通过体内/体外实验验证,同时需要评估 CKI 的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验